Federal contract award
75F40121C00109
STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.8M |
| Current contract value | $2.8M |
| Potential contract value / ceiling | $2.8M |
| Start date | Aug 27, 2021 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | Mar 3, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 3, 2026 | P00005 | $0 | MOD P00005- NO COST EXTENSION OF POP - STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60 |
| Aug 5, 2025 | P00004 | $0 | STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60 |
| Nov 21, 2024 | P00003 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO MARCH 14, 2026. |
| Jul 24, 2023 | P00002 | $0 | STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60 |
| Dec 1, 2021 | P00001 | $0 | EO14042 STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60 |
| Aug 27, 2021 | 0 | $2.8M | STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60 |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | May 26, 2021 |
| Robert Maydwell | Contact | Robert.Maydwell@fda.hhs.gov 301-348-1814 | Source | May 26, 2021 |
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | May 26, 2021 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | May 26, 2021 |
| Kimberly DeLong | Contact | kimberly.delong@fda.hhs.gov 2404028639 | Source | Jan 28, 2021 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | Jan 28, 2021 |
| Benjamin Golway | Contact | Benjamin.Golway@fda.hhs.gov 3018374464 | Source | Nov 20, 2020 |
| Anthony S. Wimbush | Contact | anthony.wimbush@fda.hhs.gov 2404027628 | Source | Nov 20, 2020 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.